Ibopamine treatment heart failure Efficacy safety drug essential criteria new drug recommendation review safety ibopamine treatment chronic heart failure Ibopamine new active drug predominant action dopaminergic adrenoceptors result systemic vascular resistance cardiac output renal flow Ibopamine neuroendocrine reflexes heart failure activity norepinephrine aldosterone plasma concentrations sustained administration Ibopamine safe many thousands heart failure patients long-term therapy use alternative additive therapy treatment patients chronic heart failure 